Tower Research Capital (TRC)’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,814
Closed -$3.59K 6384
2023
Q3
$3.59K Sell
2,814
-13,003
-82% -$16.6K ﹤0.01% 4985
2023
Q2
$5.16K Buy
15,817
+15,733
+18,730% +$5.13K ﹤0.01% 4832
2023
Q1
$0 Sell
84
-14,949
-99% ﹤0.01% 6550
2022
Q4
$8K Sell
15,033
-14,113
-48% -$7.51K ﹤0.01% 4502
2022
Q3
$21K Buy
29,146
+27,034
+1,280% +$19.5K ﹤0.01% 3917
2022
Q2
$2K Buy
2,112
+310
+17% +$294 ﹤0.01% 5653
2022
Q1
$4K Buy
1,802
+1,729
+2,368% +$3.84K ﹤0.01% 5298
2021
Q4
$0 Buy
+73
New ﹤0.01% 6764
2021
Q3
Sell
-23,194
Closed -$122K 6343
2021
Q2
$122K Buy
+23,194
New +$122K ﹤0.01% 2273
2020
Q3
Sell
-6,213
Closed -$21K 5194
2020
Q2
$21K Buy
+6,213
New +$21K ﹤0.01% 3663
2020
Q1
Sell
-4,250
Closed -$26K 4146
2019
Q4
$26K Sell
4,250
-1,298
-23% -$7.94K ﹤0.01% 1768
2019
Q3
$42K Buy
5,548
+261
+5% +$1.98K ﹤0.01% 1929
2019
Q2
$72K Buy
+5,287
New +$72K ﹤0.01% 1366
2019
Q1
Sell
-11,497
Closed -$35K 4451
2018
Q4
$35K Buy
11,497
+10,997
+2,199% +$33.5K ﹤0.01% 1539
2018
Q3
$4K Sell
500
-2,325
-82% -$18.6K ﹤0.01% 3239
2018
Q2
$28K Sell
2,825
-4,189
-60% -$41.5K ﹤0.01% 2219
2018
Q1
$61K Buy
+7,014
New +$61K 0.01% 1569
2017
Q4
Sell
-3,913
Closed -$33K 4262
2017
Q3
$33K Buy
3,913
+3,828
+4,504% +$32.3K ﹤0.01% 2368
2017
Q2
$1K Sell
85
-15
-15% -$176 ﹤0.01% 2536
2017
Q1
$2K Buy
+100
New +$2K ﹤0.01% 2691
2016
Q3
Sell
-224
Closed -$2K 4669
2016
Q2
$2K Buy
+224
New +$2K ﹤0.01% 3997
2016
Q1
Sell
-62
Closed -$1K 5161
2015
Q4
$1K Sell
62
-138
-69% -$2.23K ﹤0.01% 4208
2015
Q3
$3K Buy
+200
New +$3K ﹤0.01% 3193